Changes in plasma IL-1 β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.

This study provides a theoretical basis for the improvement of QOL in BC patients. PMID: 32655829 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research